In addition, BTK, which is expressed in about 80% of human AML, mediates FLT3-ITD-dependent Myc and STAT5 activation (17), and transcriptionally increases the levels of G1 cell cycle checkpoint proteins through c-Myc signaling (39). This evidence concerns the gene BTK and acute myeloid leukemia.